Roberto E Favoni

Summary

Affiliation: National Cancer Research Institute
Country: Italy

Publications

  1. ncbi Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma
    Roberto E Favoni
    IRCCS A O U San Martino IST, Laboratory of Gene Transfer, Genoa, Italy
    Br J Pharmacol 166:532-53. 2012
  2. ncbi Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation
    Roberto E Favoni
    Department of Oncologia Traslazionale, Lab Trasferimento Genico, Istituto Nazionale per la Ricerca sul Cancro IST Nord, B3, Rm18, Largo Rosanna Benzi, 10 16132 Genova, Italy
    Curr Cancer Drug Targets 10:176-91. 2010
  3. ncbi Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma
    Roberto E Favoni
    Department of Translational Oncology Research, Gene Transfer Laboratory, National Cancer Institute, Largo Rosanna Benzi, 10 16132 Genoa, Italy
    Trends Pharmacol Sci 32:463-79. 2011
  4. ncbi Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines
    Alessandra De Cupis
    Department of Preclinical Oncology, Laboratory of Pharmacology, Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, 10-16132 Genoa, Italy
    Eur J Pharmacol 473:83-95. 2003

Collaborators

Detail Information

Publications4

  1. ncbi Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma
    Roberto E Favoni
    IRCCS A O U San Martino IST, Laboratory of Gene Transfer, Genoa, Italy
    Br J Pharmacol 166:532-53. 2012
    ....
  2. ncbi Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation
    Roberto E Favoni
    Department of Oncologia Traslazionale, Lab Trasferimento Genico, Istituto Nazionale per la Ricerca sul Cancro IST Nord, B3, Rm18, Largo Rosanna Benzi, 10 16132 Genova, Italy
    Curr Cancer Drug Targets 10:176-91. 2010
    ..Finally, we propose that the formation of inactive EGFR dimers may contribute to the antitumoral activity of Gefitinib...
  3. ncbi Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma
    Roberto E Favoni
    Department of Translational Oncology Research, Gene Transfer Laboratory, National Cancer Institute, Largo Rosanna Benzi, 10 16132 Genoa, Italy
    Trends Pharmacol Sci 32:463-79. 2011
    ..Detailed knowledge of molecular mechanisms of signal transduction and neoangiogenesis in hMPM should aid in the design and screening of other promising compounds such as more efficacious receptor tyrosine kinase inhibitors...
  4. ncbi Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines
    Alessandra De Cupis
    Department of Preclinical Oncology, Laboratory of Pharmacology, Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, 10-16132 Genoa, Italy
    Eur J Pharmacol 473:83-95. 2003
    ....